Q3 Korean Biotech Roundup: Obesity News, AimedBio Deal Raise Hopes

More IPO Filing Activity

 
• By Jung Won Shin
  
Korean biotech
AimedBio/Boehringer Deal, Hanmi’s Phase III Obesity Success Brightens Mood (Shutterstock)

More from Start-Ups & SMEs

More from Business